Recently, direct evidence shows that cancer-associated adipocytes are found to induce tamoxifen resistance by activating the PI3K/AKT/mTOR pathway in HR+/GPER + BC,191 thereby making it necessary that more translational research efforts should be focused on this area. Here, GPER1 is linked to cancer.